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ABSTRACT 
 
PURPOSE:  Methoxyisoflavone (M), 20-hydroxyecdysone (E), and sulfo-polysaccharide (CSP3) have been 
marketed to athletes as dietary supplements that can increase strength and muscle mass during resistance-
training.  However, little is known about their potential ergogenic value.  The purpose of this study was to 
determine whether these supplements affect training adaptations and/or markers of muscle 
anabolism/catabolism in resistance-trained athletes. METHODS:  Forty-five resistance-trained males (20.5±3 
yrs; 179±7 cm, 84±16 kg, 17.3±9% body fat) were matched according to FFM and randomly assigned to ingest 
in a double blind manner supplements containing either a placebo (P); 800 mg/day of M; 200 mg of E; or, 1,000 
mg/day of CSP3 for 8-weeks during training. At 0, 4, and 8-weeks, subjects donated fasting blood samples and 
completed comprehensive muscular strength, muscular endurance, anaerobic capacity, and body composition 
analysis.  Data were analyzed by repeated measures ANOVA. RESULTS:  No significant differences (p>0.05) 
were observed in training adaptations among groups in the variables FFM, percent body fat, bench press 1RM, 
leg press 1RM or sprint peak power.  Anabolic/catabolic analysis revealed no significant differences among 
groups in active testosterone (AT), free testosterone (FT), cortisol, the AT to cortisol ratio, urea nitrogen, 
creatinine, the blood urea nitrogen to creatinine ratio.  In addition, no significant differences were seen from pre 
to post supplementation and/or training in AT, FT, or cortisol. CONCLUSION:  Results indicate that M, E, 
and CSP3 supplementation do not affect body composition or training adaptations nor do they influence the 
anabolic/catabolic hormone status or general markers of catabolism in resistance-trained males.  Journal of the 
International Society of Sports Nutrition.  3(2): 19-27, 2006 
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INTRODUCTION 
 
Numerous nutritional supplements are marketed as 
ergogenic aids to resistance-trained athletes in an 
attempt to promote increases in strength, power, 
and/or muscle mass during training.   Over the last 
few years, methoxyisoflavone, ecdysterones, and 
sulfo-polysaccharide (a purported myostatin 
inhibitor) have been marketed as potential anabolic 
promoting nutritional supplements for resistance-
trained athletes.  Unfortunately, little well-controlled 
research has been conducted to examine the potential 
ergogenic properties of these nutrients.   
Methoxyisoflavone is a member of the flavonoids 
(isoflavones) family that are primarily obtained in the 
diet from soybeans and soy foods 
1.   The two most 
popular forms of methoxyisoflavones on the market 
are 5-methyl-7-methoxy-isoflavone (Methoxyiso-
flavone) and 7-Isopropoxyisoflavone (Ipriflavone).     
Initial claims based on animal research suggested that 
methoxyisoflavone supplementation possesses a 
muscle-building and bone-building (anabolic) 
component without the side effects of traditional 
hormone replacement therapies that would give 
similar results 
1.  Despite these claims, the only 
beneficial effect of methoxyisoflavone that has been 
reported in multiple research publications and U.S. 
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patents is the benefits of reduced bone resorption and 
bone loss prevention 
2-4. 
 
Ecdysterone (20-Beta-Hydroxyecdysterone) is a plant 
sterol that has also been linked to some bold claims 
including promotion of protein synthesis, 
maintenance of anabolic state, and enhancement of 
lean muscle mass, while subsequently decreasing 
adipose tissue.  Some common names for 
ecdysterone include ecdisten, ecdysone, 
isoinokosterone, 20-hdroxyecdysone and ß-
ecdysterone.  Currently the only research supporting 
these claims has been conducted in animals where 
reports suggest ecdysterone’s lead to anabolic 
activity on skeletal muscles 
5, cell proliferation and 
growth leading to increased mass from vitamin-like 
effects 
6, improved liver secretory function 
7as they 
play a structural role in the mitochondrial membranes 
in cells 
8, as well as immunomodulating effects 
9.  
Despite these potential benefits, no research has 
supported these claims in human models. 
 
Sulfo-polysaccharide is a nutrient that is advertised to 
bind to myostatin and inhibit its activity in muscle.  
Sulfo-polysaccharide’s active ingredient is a brown 
sea algae known as cystoseira canariensis.  
Myostatin is a cytokine that works by inhibiting the 
proliferation of satellite cells and the differentiation 
of myoblasts 
10, while also decreasing adipogenesis 
via reductions in the secretion of leptin 
11.  Thus, the 
rationale for binding myostatin with sulfo-
polysaccharides would theoretically result in 
increased muscle mass and improved body 
composition.  The interest in myostatin was 
generated by recent studies where antibodies for 
myostatin were created and administered to adult 
rodents, which resulted in an increase in body mass, 
muscle mass, muscle size, and strength 
11, 12.  Despite 
the success in rodents, human models have not been 
as successful in increasing body mass and muscle 
mass 
13, but sulfo-polysaccharides have been reported 
to have a binding specificity for the myostatin 
inhibitor follistatin 
14.  Further research is needed to 
see if sulfo-polysaccharides or cystoseira canariensis 
have any beneficial effect in humans in response to 
resistance training.   
 
Despite profound claims, little is known regarding 
the effects of dietary supplementation of these 
nutrients on training adaptations in resistance-trained 
subjects.  Therefore, the purpose of this study was to 
examine the effects of methoxyisoflavone, 
ecdysterone, and sulfo-polysaccharide (CSP3) 
supplementation during resistance training on body 
composition, markers of catabolism, and training 
adaptations.  
 
METHODOLOGY 
 
Subjects. Forty-five resistance-trained males who had 
been consistently training for at least one year 
volunteered for this study. Subjects were considered 
resistance trained if they had been consistently 
training for one year, a minimum of three days per 
week.  Subjects were with 20.5 ± 3 yrs, 179 ± 7 cm, 
84 ± 16 kg, and 17.3 ± 9% body fat.  Subjects signed 
an informed consent that was approved by the 
Institutional Review Board for Human subjects prior 
to participation.  Each subject completed a personal 
information sheet and a standard medical history 
form verified by a registered nurse.  Subjects were 
free from any major metabolic disorders (i.e. heart 
disease, diabetes, thyroid disease, etc.) as well as 
major musculoskeletal disorders that would interfere 
with their ability to workout and/or complete the tests 
during the three testing sessions.  Subjects were not 
permitted in the study if they had taken any self-
reported ergogenic dietary supplements (i.e. creatine, 
androstendione, myostatin inhibitors, pro-hormones, 
etc.) within six months prior to the onset of the study.  
Subjects were asked to maintain their normal diet 
throughout the study and were not allowed to ingest 
any dietary supplement that contained potentially 
ergogenic nutrients.  However, subjects were 
permitted to ingest energy-based sports drinks, 
energy bars, and protein powders provided that they 
did not contain any ergogenic nutrients.  The reason 
for this was that many resistance-trained athletes 
ingest these energy-based supplements as a means to 
maintain their recommended dietary intake of 
calories.  This intake was considered as part of their 
normal diet and was accounted for in analysis of 
dietary intake.   
 
Experimental Design.  The study was conducted as a 
double-blind, placebo controlled trial using parallel 
groups matched according to fat free mass.  The 
independent variable was nutritional 
supplementation.  Dependent variables included: 
dietary intake, body mass, body water (total, 
intracellular, extracellular) using bioelectrical 
impedance, body composition using dual energy x-
ray absorptiometry (DEXA), upper and lower body 1 
RM strength (bench press and leg press), muscle 
endurance (80% of 1RM on bench press and leg 
press), anaerobic sprint power (Wingate cycle 
ergometer test), fasting clinical blood profiles 
(substrates, electrolytes, muscle and liver enzymes, Journal of the International Society of Sports Nutrition. 3(2): 19-27, 2006. (www.sportsnutritionsociety.org) 
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red cells, white cells), and anabolic/catabolic 
hormones (free and active testosterone, cortisol).   
 
Familiarization and Testing Sessions. Subjects were 
pre-qualified for entry into the study and then 
familiarized to the experimental design and practiced 
the exercise tests in order to get acquainted with the 
nature of the equipment and protocol prior to baseline 
testing.  Subjects were scheduled for their first testing 
session and all questions and concerns were answered 
at this time. 
 
Prior to baseline testing (T1), subjects recorded 
dietary intake on diet record forms for 4-days (three 
weekdays and one weekend day).  Dietary records 
were analyzed by a registered dietitian using ESHA 
Research Inc. (Salem, OR) nutritional software.   
Subjects were instructed to abstain from exercise or 
physical activity for 48 hours prior to testing and 
were instructed to fast at least 10 hours prior to the 
baseline blood draw.  On the day of baseline testing, 
subjects reported to the lab and completed 
questionnaires and information sheets.  Height was 
measured using standard anthropometry and total 
body weight was measured using a calibrated 
electronic scale with a precision of ± 0.02 kg (Health-
O-Meter, Bridgeview, IL).  Whole-body composition 
was estimated by certified personnel using a Hologic 
QDR-4500W dual-energy x-ray absorptiometry 
(DEXA) using Hologic software version 9.80C 
(Waltham, MA).  This test evaluates body 
composition and body density by scanning the entire 
body with a low dose of radiation.  Test-retest 
reliability studies performed on male athletes with 
this DEXA machine yielded a mean deviation for 
total bone mineral content and total fat free/soft 
tissue mass of 0.31% with a mean intra-class 
correlation of 0.985. This method of determining 
body composition has been shown to be valid 
15.   
 
Following the DEXA, subjects donated 
approximately 20 ml of fasting blood from the 
antecubital vein in the arm via venipuncture using 
standard and sterile procedures.  Blood was analyzed 
for basic clinical chemistry  profiles for safety 
measures [glucose, protein, blood urea nitrogen 
(BUN), creatinine, uric acid, aspartate 
aminotransferase (AST), alanine aminotransferase 
(ALT), creatine kinase (CK), lactate dehydrogenase 
(LDH), gamma glutamyl transaminase (GGT), 
triglycerides, cholesterol] and whole blood cell 
counts [including hemoglobin, hematocrit, red blood 
cell counts, mean corpuscle volume (MCV), mean 
corpuscle hemoglobin (MCH), mean corpuscle 
hemoglobin concentration (MCHC), red cell 
dimension width (RDW), white blood cells (WBC), 
neutrophils, lymphocytes, monocytes, basophils, and 
eosinophils] by Quest Diagnostics (Dallas, TX).  
Blood serum samples were stored for later analysis of 
the anabolic/catabolic hormones (active testosterone, 
free testosterone, and cortisol) via assays in the 
Exercise and Biochemical Nutrition Laboratory.   
  
Subjects first warmed-up (2 sets of 8 – 10 repetitions 
at approximately 50% of anticipated maximum) on 
the bench press.  Subject’s then performed successive 
1-RM lifts starting at about 70% of anticipated 1-RM 
and increasing by 5 – 10 lbs until the subject reached 
their 1-RM.  After the acquisition of max the 
participant rested five minutes and completed as 
many repetitions as possible at 80% 1-RM to assess 
muscular endurance.  Subjects were instructed on 
proper technique and mechanics of the movement.   
Hand position was also recorded to ensure test re-test 
reliability.  Subjects then rested for 10 minutes and 
warmed-up on the Nebula 45° Leg press (2 sets of 8 – 
10 repetitions at approximately 50% of anticipated 
maximum).  Subjects then performed successive 1 
RM lifts on the leg press starting at about 70% of 
anticipated 1RM and increasing by 10 – 25 lbs until 
reaching the subject’s 1RM.  Subjects then perform 
an 80% of 1RM endurance repetition tests on the 
hip/leg sled. Foot placement and sled height were 
recorded to ensure test re-test reliability.  All strength 
testing was supervised by a Certified Strength and 
Conditioning Specialist (CSCS).  Test re-test 
reliability of performing these strength tests on 
resistance-trained subjects in our laboratory have 
yielded low mean coefficients of variation and high 
reliability for the bench press (1.9%, intraclass r = 
0.94) and leg press/hip sled (0.7%, intraclass r = 
0.91).  
 
Following the strength assessments and 10 minutes of 
rest, subjects then perform a 30-second Wingate 
anaerobic capacity test using a Lode computerized 
cycle ergometer (Groningen, Netherlands).  
Correlation coefficients of test-retest reliability for 
absolute peak power and mean power in our lab has 
been found to be r = 0.69 and r = 0.95, respectively.   
Subjects replicated all testing after 4 and 8 weeks of 
training and supplementation.  
 
Supplementation Protocol.  Subjects were matched 
into one of four groups according to fat free mass. 
Subjects were then randomly assigned to ingest in a 
double blind manner capsules containing a dextrose 
placebo (P); 800 mg/day of methoxyisoflavone (M) 
(MuscleTech Research & Development, Inc., 
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Vulare/Suma root standardized for 30 mg of 20-
hydroxyecdysone (E); or, 500 mg/day of sulfo-
polysaccharides (CSP3) extracted from Cystoseira 
canariensis (Biotest Labs, Colorado Springs, CO).  
Subjects ingested the assigned capsules in the 
morning once per day for 8-weeks.  The supplements 
were prepared in capsule form and packaged in 
generic bottles for double blind administration by 
MuscleTech Research & Development, Inc., 
(Mississauga, ON).  Supplementation compliance 
was monitored by research assistants by having the 
subjects return empty bottles of the supplement at the 
end of 4 and 8 weeks of supplementation. 
 
Training Protocol.  Subjects participated in a 
periodized 4-day per week resistance-training 
program split into two upper and two lower extremity 
workouts per week for a total of 8-weeks.  Prior to 
the workout, subjects performed a standardized series 
of stretching exercises as a warm-up.  Subjects then 
performed an upper body resistance-training program 
consisting of nine exercises (bench press, lat pull, 
shoulder press, seated rows, shoulder shrugs, chest 
flys, biceps curl, triceps press down, and abdominal 
curls) twice per week.  Subjects also performed a 
seven-exercise lower extremity resistance-training 
program that could include (leg press, squat, back 
extension, step-ups, leg curls, leg extension, heel 
raises, and abdominal crunches) twice per week.  The 
program was standardized at 3 sets of 10 repetitions 
with as much weight as they could lift per set 
(typically 60 – 80% of 1RM) with no more than 2-
minute rest periods between sets and no more than 3 
minutes of rest between exercises.  All training was 
conducted at the Student Life Center (SLC) at Baylor 
University.  Subjects recorded the amount of weight 
lifted and number of repetitions performed for each 
set on training cards so that training volume could be 
determined.  Subjects were also instructed to have 
their exercise card signed by SLC staff in order to 
verify attendance and completion of the workouts.  
 
Blood and Serum Analysis.  Two serum separation 
vacutainer tubes and one EDTA vacutainer tube was 
obtained from each subject.  The serum vacutainers 
were separated via centrifugation a 6,000 rpm for 20 
minutes.  One serum separation tube and the EDTA 
tube were sent to Quest Diagnostics (Dallas, TX) for 
assay of a standard clinical chemistry profile and 
whole blood cell counts to ensure safety of 
supplementation during the protocol.  The serum 
from the remaining separation tube was separated, 
labeled, and stored in micro centrifuge tubes at -80˚C 
for later analysis.  Following completion of the study, 
samples were analyzed for active testosterone, free 
testosterone, and cortisol with an enzyme 
immunoassay (EIA) assays using Goat-Anti-rabbit 
IgG (GARG) coated microplates.  EIA kits were 
purchased from Diagnostic Systems Laboratories 
(Webster, TX).  Assays were performed using a 
Jitterbug microplate shaker (Boekel Scientific- 
Philadelphia, PA) and a Tricontinent Multiwash 
Advantage microplate washer (Grass Valley, CA).   
The assays were run in duplicate and the absorbances 
of the standards, samples, and controls were 
determined at an optical density of 450 nanometers 
with a Wallac Victor
2 1420 Multilabel counter by 
PerkinElmer (Boston, MA).  Concentrations of active 
testosterone, free testosterone, and cortisol were 
expressed relative to changes in blood serum content.  
Intra-assay coefficients of variation were 5.3% and 
6.8%, 7.5% and 5.4%, and 2.4% and 5.0%, 
respectively, for active testosterone (control I and II), 
free testosterone (control I and II), and cortisol 
(control I and II).  Inter-assay coefficients of 
variation were 4.8% and 4.9%, 0.22% and 1.28%, 
and 12.0% and 6.1%, respectively, for active 
testosterone (control I and II), free testosterone 
(control I and II), and cortisol (control I and II). 
 
Data Analysis.  Data were analyzed using SPSS 11.5 
for Windows (Chicago, Illinois).  A repeated 
measures analysis of variances (ANOVA) was used 
for the analysis of the univariate means on the 
dependent variables and is presented in means and 
standard deviations.  Delta scores (post and pre 
values) were calculated on selected variables and 
analyzed by ANOVA for repeated measures.  Date 
were considered significant when the probability of 
Type I error was 0.05 or less.   Significant group x 
time interactions were evaluated by least significant 
differences (LSD) post-hoc analysis to determine 
where the significance existed.  Power analysis in a 4 
x 3 design indicate that an n-size of 15 per group 
yields high power (>0.9) for delta values of 0.75 to 
1.25.  Data are presented as means ± SD changes 
from baseline.  
 
RESULTS 
 
Side Effects.  Analysis of post study questionnaires 
revealed that subjects tolerated the supplementation 
protocol well with no reports of medical problems or 
symptoms. 
 
Training Volume and Dietary Intake.  No 
statistically significant differences were observed 
among groups in total lifting volume during the 
training period for upper body (P 322,984 ± 106,936; 
M 304,987 ± 51,955; E 275,744 ± 72,658; CSP3 Journal of the International Society of Sports Nutrition. 3(2): 19-27, 2006. (www.sportsnutritionsociety.org) 
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313,308 ± 112,077 kg; p = 0.83) and lower body (P 
398,976 ± 77,553; M 408,966 ± 113,746; E 448,371 
± 189,738; CSP3 422,163 ± 167,259 kg; p = 0.94).   
Table 1 presents caloric intake data observed among 
groups throughout the trial.  No significant group or 
group x time effects were observed in mean daily 
total caloric carbohydrate, protein, or fat intake.    
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Body Mass and Body Composition. Figure 1 presents 
mean changes in body mass and body composition 
for the P, M, E, and CSP3 groups.  Training resulted 
in a statistically significant increase (p = 0.03) in 
DEXA fat free mass (lean/soft tissue mass plus bone 
mineral content) for all groups.  However, no 
statistically significant differences were observed 
among the P, M, E, and CSP3 groups, respectively, in 
mean fat free mass (P 0.94 ± 1.5; M 0.29 ± 1.4; E -
0.04 ± 1.3; CSP3 0.64 ± 1.4 kg, p = 0.40), fat mass 
(P0.69 ± 1.1; M 0.32 ± 1.6; E 0.69 ± 1.1; CSP3 -
0.36±0.7 kg, p = 0.17), percent body fat (P 0.59 ± 
1.7; M 0.08 ± 1.7; E 0.70 ± 1.0; CSP3 -0.46 ± 0.8 %, 
p = 0.18), or total body water (P 0.39 ± 3.3, M 0.16 ± 
2.9, E 1.7 ± 2.5, CSP3 0.31 ± 2.4 L,  p = 0.61).    
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Change in body composition variables (mean + SD) fat 
free mass (FFM), fat mass (FM) and body fat (BF) between 
groups following 8 weeks of resistance training and 
supplementation. 
 
 
Training Adaptations.  Training resulted in 
statistically significant increase in 1-RM bench press 
(pre: 94.94 ± 22.8 to post: 100.84 ± 20.54 kg, p = 
<0.0001) and 1-RM leg press (311 ± 76 to 341 ± 82 
kg, p = <0.0001) for all groups.  No statistically 
significant interactions were observed among P, M, 
E, and CSP3 groups, respectively, in mean changes in 
bench press 1-RM (6.2 ± 7; 2.5 ± 5; 7.2 ± 10; 7.7 ± 6 
kg, p=0.29), leg press 1-RM (20.6 ± 33; 37.0 ± 39; 
38.9 ± 45; 29.3 ± 36 kg, p=0.63). Bench press lifting 
volume was significantly greater in the M group (105 
± 120; 102 ± 200; 124 ± 174; 25 ± 176 kg, p=0.008) 
while leg press lifting volume was lower in the M 
group (97 6± 1,213; -799 ± 1,718; 1,259 ± 1,153; 978 
± 2,328 kg, p = 0.04).  Likewise, no significant 
differences were observed in mean changes in 
Wingate peak power (82 ± 248; 30 ± 139; 28 ± 151; 
17 ± 171 W, p=0.82), Wingate mean power (20 ± 83; 
-13 ± 88; -18 ± 76; -15 ± 52 W, p=0.55), or Wingate 
total work (582 ± 2,564; -216 ± 2,716; -420 ± 2,291; 
-528 ± 1,514 J, p = 0.29).    
 
 
 
 
 
 
 
 
 
 
Figure 2. Change in bench press and leg press 1-repetition 
maximum levels (mean + SD) between groups following 8 weeks 
of resistance training and supplementation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Change in Wingate sprint performance (mean + SD) 
between groups following 8 weeks of resistance training and 
supplementation. 
 
 
Blood Chemistry Profiles. No statistically significant 
differences were observed among groups as well as 
over time for the clinical chemistry profiles on 
variables including serum protein (p = 0.65), uric 
acid (p = 0.57), AST (p = 0.16), ALT (p = 0.56), 
GGT (p = 0.86), triglycerides (p = 0.62), and total 
cholesterol (p = 0.48).  No statistically significant 
differences were observed among groups as well as 
over time in the whole blood cell count variables 
including hemoglobin  (p = 0.74), hematocrit (p = 
0.61), red blood cell counts (p = 0.39), MCV (p = 
0.68), MCH (p = 0.20), MCHC (p = 0.29), WBC (p = 
0.076), lymphocytes (p = 0.44), monocytes (p = 
0.66), and eosinophils (p = 0.28) from whole blood 
analysis.  However, significant changes were seen in 
neutrophils (2.05 ± 9.9; 4.4 ± 10.1; 4.3 ± 5.5, 5.8 ± 
7.4 k/µL:, p = 0.04) and basophils (7.5 ± 7.6; 7.6 ± 
25.1; 6.57 ± 16.1; 4.4 ± 7.8 k/µL, p = 0.04).   All 
values remained within normal clinical ranges.  
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Table 1.  Dietary intake data for the P, M, E, and CSP3 groups.   
Variable/Group   T1   T2   T3   Significance 
 
Protein (g/kg/d) 
P      1.6 ± .7      1.7 ± .85    1.5 ± .6    Group    .577           
M      1.5 ± .68    1.4 ± .53    1.4 ± .52    Time    .068 
   E      1.7 ± .34    1.7 ± .34    1.4 ± .44    GxT    .815 
   CSP3      1.4 ± .41    1.4 ± .41    1.3 ± .59 
 
Fat (g/kg/d) 
   P      1.7 ± .5      1.5 ± .5      1.3 ± .8    Group    .866 
   M      1.7 ± 1.6    1.3 ± .6      1.2 ± .49    Time    .092 
   E      1.5 ± .8      1.2 ± .29    1.2 ± .39    GxT    .670 
   CSP3      1.1 ± 1.3    1.5 ± 1.3    1.0 ± .42 
 
Carbohydrates (g/kg/d) 
   P      5.5 ± 3.5    4.6 ± 1.4    4.2 ± 1.3    Group    .293 
   M      3.5 ± 1.7    3.5 ± 1.7    4.0 ± 2.3    Time    .001 
   E      4.7 ± 1      3.8 ± .83    3.9 ± 1.2    GxT    .491 
   CSP3      3.8 ± 1.7    3.4 ± 1.6    3.4 ± 1.7 
 
Total Calories (kcal/kg/d) 
   P      40 ± 10      39 ± 11     41 ± 37    Group    .331 
   M      40 ± 28      31 ± 13      32 ± 15    Time    .274 
   E      40 ± 12      31 ± 6      32 ± 7    GxT    .826 
   CSP3      30 ± 12      29 ± 13      28 ± 11 
Data are means and ± standard deviations 
 
 
 
Table2.  Selected markers of catabolism for the P, M, E, and CSP3 groups. 
Variable/Group   T1   T2   T3   Significance 
 
Creatinine (mg/dl) 
   P      1.15 ± .11    1.14 ± .14    1.2 ± .1    Group    .812 
   M      1.2 ± .14    1.2 ± .13    1.2 ± .13    Time    .891 
   E      1.2 ± .13    1.1 ± .16    1.2 ± .13    GxT    .537 
   CSP3      1.1 ± .17    1.1 ± .15    1.1 ± .12 
 
BUN (mg/dl) 
   P      16.9 ± 3.3  14.4 ± 3.7  16   ±  3.3  Group    .959 
   M      16.1 ± 3.5  14.9 ± 3.5  15.1 ±  4.4  Time    .041 
   E      16.2 ± 3.1  15 ± 2.7    14.7 ±  3.3  GxT    .970 
   CSP3      16.3 ± 2.6  14.8 ± 3.5  15.1 ±  2.6 
 
CK (IU/L) 
   P      207 ± 1088  652 ± 1556  250 ± 188  Group     .644 
   M      198 ± 98    171 ± 78  2  45 ± 188    Time    .383 
   E      172 ± 83    228 ± 133  159 ± 64    GxT    .091 
   CSP3      594 ± 108  174 ± 90    346 ± 614 
 
LDH (IU/L) 
   P      132 ± 15    143 ± 36    135 ± 24    Group    .114 
   M      139 ± 16    138 ± 22    150 ± 22    Time     .752 
   E      126 ± 23    124 ± 12    124 ± 14    GxT    .359 
   CSP3      150 ± 33    137 ± 14    141 ± 17 
 
Cortisol (µg/dl) 
   P      16.5 ± 5.7  14.6 ± 5.2  13.8 ± 3.5  Group    .706 
   M      13.2 ± 4.3  13.2 ± 4.3  15.5 ± 5.1  Time    .222 
   E      17.1 ± 4.5  15.6 ± 5.3  15.1 ± 5.8  GxT    .571 
   CSP3      16.7 ± 9.5  17.5 ± 5.7  15.0 ± 5.6 
Data are means and ± standard deviations 
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Anabolic/Catabolic Status. Table 2 presents selected 
markers of anabolic and catabolic status while Figure 
4 & 5 show changes in free and active testosterone 
for the P, M, E, and CSP3 groups.  No statistically 
significant differences were observed among P, M, E, 
and CSP3 groups, respectively, in changes in total 
testosterone (0.21 ± 0.83, 0.26 ± 1, 0.02 ±1.21, 0.10 ± 
0.93 ng/ml, p = 0.67), free testosterone (4.39 ± 10.4, 
5.54 ± 6.85, 1.39 ± 11.84, 1.77 ± 8.62 pg/ml, p = 
0.25), cortisol (2.68 ± 2.46, 1.11 ± 6.3, 1.93 ± 5.57, 
1.66 ± 10.54 µg/dl, p = 0.57), total testosterone to 
cortisol ratio (0.05 ± 0.09, 0.02 ± 0.16, 0.06 ± 0.17, 
0.02 ± 0.16, p = 0.43).  In addition, no differences 
were observed from pre to post testing for all 
variables in Table 2.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Change in serum free testosterone levels (mean + SD) 
between groups following 8 weeks of resistance training and 
supplementation. 
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Figure 5.  Change in serum active testosterone levels (mean + 
SD) between groups following 8 weeks of resistance training and 
supplementation. 
 
 
DISCUSSION 
 
The purpose of this study was to determine whether 
methoxyisoflavone, 20-hydroxyecdysone, or sulfo-
polysaccharide supplementation affects muscle mass, 
training adaptations, or markers of muscle growth 
and/or breakdown in resistance-trained males.  The 
major finding of this study was that dietary 
supplementation of commercially available 
supplements containing methoxyisoflavone, 
ecdysterone, and sulfopolysaccharide (CSP3) did not 
significantly affect anabolic or catabolic responses to 
resistance training, body composition, or training 
adaptations.  These findings do not support 
contentions that methoxyisoflavone, ecdysterone, and 
sulfopolysaccharide (CSP3) supplementation during 
resistance training enhance gains in strength, power 
or muscle mass.  
  
Isoflavones are naturally occurring non-steroidal 
phytoestrogens found primarily in soy beans 
1.  5-
methyl-7-methoxy-isoflavone is believed to play a 
role in increased protein synthesis and muscle 
accretion.  They are also believed to reduce body fat, 
lower cholesterol levels, promote endurance, increase 
vitality, and the body's ability to use oxygen.  The 
primary foundation of these beliefs have been data 
described in a U.S. patent in the early 1970’s 
16, 17.  
Feurer et al 
16, 17 reported lower cortisol levels, 
increased protein synthesis, and improved overall 
recovery from exercise as a result of isoflavone 
supplementation in animals.  Preliminary results from 
a study only available in abstract form 
18 evaluated 
the effects of 5-methyl-7-methoxyisoflavone 
supplementation (800 mg/day for 8-weeks) on 
training adaptations in 14 resistance-trained men.   
Inclendon et al
18 reported 5-methyl-7-
methoxyisoflavone supplementation did not 
significantly affect changes in body weight, body 
mass index, bone mineral content, or isokinetic peak 
force between groups.  However, DEXA determined 
FFM increased by 1.3 kg in the methoxyisoflavone 
group while being unchanged (0.1 kg) in the placebo 
group resulting in a significant reduction in body fat 
percent.  Results of the present study do not support 
the purported ergogenic value of 5-methyl-7-
methoxyisoflavone supplementation in resistance-
trained males.   
 
Ecdysterones have also been recently purported to 
enhance training adaptations during resistance 
training.  In support of this contention, research in 
animal models has suggested that ecdysterone 
supplementation can promote anabolic activity in 
skeletal muscle 
5, as well as increase cell proliferation 
and growth, which can lead to an increase in muscle 
mass 
6.  Russian scientists’ have been evaluating the 
effects of ecdysterones for years.  Oral administration 
of Leuza (herbal ecdysterone)  in male albino mice 
caused a statistically significant increase in the time 
of running 
19.  After 20 days of supplementation, 
there was a significant increase in work capacity.   
The same researchers evaluated the effects of 20-day 
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administration of ectisten-containing tincture of 
leuzea and leveton on humoral immunity of track and 
field runners for distances of 5,000 and 10,000 m.   
Intensive cyclic physical activity induced significant 
decrease of IgG and IgA in blood serum of the 
athletes.  These researchers concluded that both 
supplements contributed to restoration of the lowered 
IgG and IgA, while the working capacity of the 
athletes grew by 10 to 15% 
20.  Furthermore, 
Chermnykh et al 
5 compared beta-ecdysterone with 
dianabol which is an extremely powerful anabolic 
steroid, suggesting both beta-ecdysterone and 
dianabol increased the size and strength of the 
muscles.  These researchers concluded that 
ecdysterone had a greater anabolic action on the 
contractile proteins of the skeletal muscles than 
dianabol.   
 
The most often cited scientific study on ecdysterone 
was published in Scientific Sports Bulletin by 
Simakin 
21.  This study sought to determine the effect 
of ecdysterone on muscle tissue mass and fat mass, 
while testing for hormonal changes in the subjects.  
Seventy-eight highly trained male and female athletes 
served as subjects in one of three experimental 
groups: protein, protein and ecdysterone, and 
placebo.  Those consuming just protein, showed only 
a slight increase in muscle mass for the 10 day period 
of time, while the placebo group experienced a slight 
reduction in lean muscle.  The addition of 
ecdysterone in conjunction with protein intake 
resulted in a 6-7% increase in lean muscle tissue with 
nearly a 10% reduction in fat.  Finally,  Gadzhieva 
and colleagues 
22 reported that 3-weeks of Ekdisten, 
leveton, and Prime Plus (combination of Ekdisten 
and pure protein) supplementation during training 
increased skinfold determined muscle mass, 
decreased fat mass, and increased total work during 
training.   Additionally, Ekdisten and Prime Plus 
supplementation appeared to promote the greatest 
gains during training.  These studies found that 
ecdysterone might increase work capacity, decrease 
fat mass, and increase lean muscle mass. 
 
Results of the present study contrast these reports.  In 
this regard, ecdysterone supplementation had no 
significant effects on body mass, body composition, 
strength, or markers of anabolic and catabolic status.  
Since most of the previous studies reporting positive 
effects of ecdysterones have been reported in obscure 
journals with limited details available to evaluate the 
experimental design and quality of the research, it is 
difficult to compare results.  Nevertheless, present 
findings do not support the purported ergogenic 
benefit of ecdysterone supplementation in resistance-
trained males.    
 
The last supplement investigated was sulfo-
polysaccharide, which is advertised to bind to 
myostatin and inhibit its activity in skeletal muscle.  
Of the three supplements examined in our study, 
sulfo-polysaccharide supplementation has the best 
theoretical rationale as a potential ergogenic aid.   
Myostatin is a cytokine that works by inhibiting the 
proliferation of satellite cells and the differentiation 
of myoblasts 
10.  Research in mice has shown that 
binding or blocking myostatin results in dramatic 
increases in body mass, muscle mass, muscle size, 
and strength following administration of antibodies 
that are specific for the cytokine myostatin 
11, 12.  To 
date, only one human study has administered sulfo-
polysaccharides in conjunction with a resistance 
training protocol 
13.  This study examined 12-weeks 
of resistance training and cystoseira canariensis 
supplementation on serum levels of myostatin and 
muscle strength and body composition in twenty-two 
untrained males.  Training consisted of three days per 
week using 3 sets of 6 to 8 repetitions at 85-90 % 1 
RM. The researchers concluded that 12-weeks of 
heavy resistance training and 1200 mg/d of cystoseira 
canariensis supplementation appeared to be 
ineffective at inhibiting serum myostatin and 
increasing muscle strength and mass or decreasing fat 
mass.  The explanation for the dramatic effects in 
animals while no observed effects in humans 
probably lies in the fact that myostatin specific 
antibodies were used in the animal model, while 
human models use sulfo-polysaccharides that are 
only advertised to bind to myostatin.  Results of this 
study support this prior report in that CSP3 
supplementation had no significant effects on body 
composition, training adaptations, or markers of 
anabolic/catabolic status in resistance-trained men. 
 
Based on the results of this study, we conclude that 
supplementation of methoxyisoflavone, ecdysterone, 
and/or sulfo-polysaccharides (CSP3) do not have any 
affect on training adaptations and/or 
anabolic/catabolic status in resistance-trained 
subjects.  These findings contrast marketed claims 
that these nutrients promote muscle accretion, 
increase anabolic status, decrease adipose tissue, 
and/or enhance training adaptations in resistance-
trained athletes.  These data are representative of a 
specific training protocol as well as specific 
prescribed doses of the experimental supplements, 
but the doses used represent the recommended 
amount found in these types of supplements.   
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